UPDATE: Barclays Upgrades Gilead Sciences (GILD) to Equalweight
Tweet Send to a Friend
(Updated - October 31, 2022 6:51 AM EDT)
Barclays analyst Carter Gould upgraded Gilead Sciences (NASDAQ: GILD) from Underweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst Carter Gould upgraded Gilead Sciences (NASDAQ: GILD) from Underweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
